Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Receivables - Net came in at $654.4 million in Q2 2026, down 11.47% on a YoY basis from $739.2 million in Q2 2025, and up 5.62% quarter-over-quarter from $619.6 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Receivables - Net for 5 consecutive years, with $654.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables - Net fell 11.47% year-over-year to $654.4 million; the trailing twelve-month figure through Jun 2026 stood at $654.4 million (down 11.47% YoY), and the FY2025 full-year result was $589.7 million, down 10.58% from the prior year.
  • Receivables - Net improved to $654.4 million in Q2 2026 per FTRE's latest filing, from $619.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.0 billion in Q3 2023 and bottomed at $589.7 million in Q4 2025.
  • Historically, Receivables - Net has averaged $785.4 million across 5 years, with a median of $709.0 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net plunged 37.13% in 2024, then advanced 15.88% in 2025.
  • Over 5 years, Receivables - Net stood at $1.0 billion in 2022, then fell by 3.3% to $988.5 million in 2023, then plunged by 33.28% to $659.5 million in 2024, then slipped by 10.58% to $589.7 million in 2025, then climbed by 10.97% to $654.4 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $654.4 million, $619.6 million, and $589.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn
6 Evotec SE 642.83 Mn 216.96 Mn -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 654.40 Mn
Mar 31, 2026 619.60 Mn
Dec 31, 2025 589.70 Mn
Sep 30, 2025 663.20 Mn
Jun 30, 2025 739.20 Mn
Mar 31, 2025 729.00 Mn
Dec 31, 2024 659.50 Mn
Sep 30, 2024 689.10 Mn
Jun 30, 2024 637.90 Mn
Mar 31, 2024 941.00 Mn
Dec 31, 2023 988.50 Mn
Sep 30, 2023 1.05 Bn
Jun 30, 2023 1.01 Bn
Dec 31, 2022 1.02 Bn